TI
CNST

Trexquant Investment’s Constellation Pharmaceuticals, Inc. CNST Stock Holding History

Trexquant Investment’s Portfolio CNST Stock Details CNST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-10,588
Closed -$305K – 1623
2020
Q4 		$305K Buy
+10,588
New +$267K 0.03% 681
2020
Q2 		– Sell
-10,156
Closed -$319K – 1593
2020
Q1 		$319K Buy
+10,156
New +$353K 0.02% 831

Other funds holding CNST

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CG
Column Group San Francisco, California $101M AUM 290.34% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Lord, Abbett & Co
Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return
PM
Ponoi Management San Francisco, California $73.2M AUM 23.44% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return

Trexquant Investment's CNST Position: Q1 2021 in Review

Trexquant Investment sold out of Constellation Pharmaceuticals, Inc. (CNST) in Q1 2021, closing a stake of 10,588 shares — an estimated $305K sold.

Trexquant Investment first reported a position in CNST in Q1 2020 and held it in 2 quarters. The position peaked at $319K in Q1 2020. 131 funds tracked by Wall St. Rank hold CNST as of Q1 2021.

  • Trexquant Investment reported no remaining Constellation Pharmaceuticals, Inc. position as of Q1 2021 after selling out during the quarter.
  • Trexquant Investment sold 10,588 Constellation Pharmaceuticals, Inc. shares in Q1 2021, an estimated $305K.
  • Trexquant Investment first reported a position in Constellation Pharmaceuticals, Inc. in Q1 2020 and held it in 2 quarters.
  • Trexquant Investment's Constellation Pharmaceuticals, Inc. position peaked at $319K in Q1 2020.
  • 131 funds tracked by Wall St. Rank held Constellation Pharmaceuticals, Inc. as of Q1 2021.

Based on Trexquant Investment's 13F filing for Q1 2021, filed 13 May 2021.